Tpharm.info


Dosage for zolpidem





Low-Dose Zolpidem Gets FDA Okay for Wee-Hours Awakening

6/11/2014
04:48 | Author: David Perry

Dosage for zolpidem
Low-Dose Zolpidem Gets FDA Okay for Wee-Hours Awakening

A new formulation of the insomnia drug zolpidem tartrate (Ambien) has been approved with a lower dosage, and with a different brand name.

A new formulation of the insomnia drug zolpidem tartrate (Ambien) has been approved with a lower dosage, and with a different brand name, to treat middle-of-the-night awakenings followed by difficulty returning to sleep, the FDA said.

Earn Free CME Credits by reading the latest medical news in your specialty.

This survey is a poll of those who choose to participate and are, therefore, not valid statistical samples, but rather a snapshot of what your colleagues are thinking.

MedPageToday, powered by Everyday Health Inc., is a trusted and reliable source for clinical and policy coverage that directly affects the lives and practices of health care professionals.

Personalize your news feed.

Published: Nov 23, 2011.

"For people whose insomnia causes them to wake in middle of the night with difficulty returning to sleep, this new medication offers a safer choice than taking a higher dose of zolpidem upon waking," said Robert Temple, MD, deputy center director for clinical science in the FDA's Center for Drug Evaluation and Research, in a statement.

In contrast, the standard Ambien dose is 10 mg.

Physicians and other healthcare professionals may also receive Continuing Medical Education (CME) and Continuing Education (CE) credits at no cost for participating in MedPage Today-hosted educational activities.

The agency said the low-dose formulation was evaluated in two clinical trials with more than 370 patients.

Comments (1)Read more



Sleep drug dosage change aims to avoid daytime drowsiness

4/10/2014
06:56 | Author: Emma Coleman

Dosage for zolpidem
Sleep drug dosage change aims to avoid daytime drowsiness

Last week, the FDA urged doctors to lower the starting dose of zolpidem, a popular prescription sleep aid, due to concerns that the drug can.

But sleep drugs aren’t right or necessary for everyone. Changing sleep habits and behavior can be helpful for people with occasional or short-term insomnia. This includes adopting a regular sleep schedule, creating a comfortable sleeping environment, avoiding alcohol and caffeine close to bedtime, and other steps known as “sleep hygiene.” (See Dr. Winkelman’s 10 tips for a good night’s sleep. ).

If you do need an over-the-counter or prescription sleep aid, take it as directed and at the lowest dose that helps you sleep in order to prevent daytime drowsiness.

Comments (2)Read more

Alert FDA Recommends Lower Doses of Sleep Meds for Women

12/19/2014
02:16 | Author: Lauren Ross

Dosage for zolpidem
Alert FDA Recommends Lower Doses of Sleep Meds for Women

The goal in lowering dosage of zolpidem medications is to lower the levels of the medication in the blood by morning, thereby reducing the risk.

by Michael J. Breus, PhD.

February 12th, 2013 at 11:13 pm Kim Daunt-tingle :

Patient Education and Compliance.

Cognitive-Behavioral Therapy (CBT): I’ve written before about the power of CBT in improving sleep. Studies show that CBT can be as effective or even more effective than drug therapy. And this type of therapy doesn’t always have to be an extended, long-term endeavor: Research shows that targeted, short-term behavioral therapy can improve sleep for people with insomnia.

February 12th, 2013 at 11:04 pm Kim Daunt-tingle :

Meditation and Relaxation : Mind-body therapies such as meditation and relaxation can also help to improve sleep, and diminish symptoms of insomnia and other sleep disorders.

Comments (3)Read more

Ambien Dosages FDA Requires Lower Doses For Sleeping Pills

10/18/2014
12:32 | Author: Emma Coleman

Dosage for zolpidem
Ambien Dosages FDA Requires Lower Doses For Sleeping Pills

The new doses apply to all insomnia treatments containing the drug zolpidem, which is sold under brands including Ambien, Edluar, Zolpimist.

FDA analysis was unable to determine why women metabolize zolpidem so much more slowly than men. According to FDA staff, the difference cannot be accounted for by usual factors like size and weight.

"But in most cases it was very difficult to determine if the driving impairment was actually related to zolpidem," Unger said. "Usually the reports did not contain information about when the accident happened or how much time had lapsed since taking the drug.".

The agency said Thursday that new research shows that the drugs remain in the bloodstream at levels high enough to interfere with alertness and coordination, which increases the risk of car accidents.

The FDA has received more than 700 reports of driving-related problems connected to zolpidem over the years.

For now, patients should continue taking their currently prescribed dose until they can talk to their doctor about the best way to proceed.

Regulators are ordering drug manufacturers to cut the dose of the medications in half for women, who process the drug more slowly.

Comments (4)Read more